Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 May 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors AbbVie
- 07 Jun 2017 Biomarkers information updated
- 31 Jan 2017 Planned End Date changed from 1 Oct 2018 to 1 Jan 2019.
- 31 Jan 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Jan 2019.